Integrated Clinical Trials with Expert Partnerships and Elevated Standards

That’s How Research Works.

We’re on a mission to revolutionize clinical research by perfecting the centralized approach; seamlessly merging elite clinicians with our cutting-edge operational frameworks. Streamlining research and reducing administrative overlap, that’s what we do.

YOUR INPUT. OUR PASSION.

THE LATEST

SCOPE Summit 2024 – Orlando

Kaye Doiron, CEO and Founder recently took the stage at the SCOPE Summit 2024 in Orlando.

The SCOPE Summit, now in its 15th year, has consistently been a melting pot of ideas and strategies, fostering joint efforts to advance our medical knowledge in ways that directly benefit patients and stakeholders. This year’s event offered a dynamic four-day program of discussions, uniting over 4,000 professionals from 850 organizations around the globe, to network, and showcase innovative solutions critical for advancing clinical operations, trials, and research.

Click to learn more how insights gained not only enhance our capabilities, but also in reinforce our relationships with major partners as Research Works expands globally.

Our Mission Unites All Stakeholders

GLOBAL REACH & DIVERSITY

SETTING GLOBAL STANDARDS

EFFICACY & TRANSPARENCY

GLOBAL REACH & DIVERSITY

Forging partnerships with established medical practices to extend clinical trial participation across the US, EU, and Puerto Rico, promoting diversity and inclusivity in research.

We’ve established centers in Puerto Rico, emphasizing a multicultural and diverse staff, as a direct response to the noticeable underrepresentation of the Latino population in clinical trials. While the Hispanic community makes up a significant demographic, their minimal participation in research affects the evolution of tailored treatments.

SETTING GLOBAL STANDARDS

We’re reshaping clinical trial sites by placing clinicians and patients at the core of our operational systems. This approach ensures sustained, meaningful benefits for patients in the long run.

Setting us apart is our in-house, hands-on, bench to bedside training provided at all our locations, ensuring the sustainability of trial sites and promoting research opportunities and careers within our communities. By relieving clinicians of administrative burdens through efficient centralization, we enable wholehearted research engagement, making clinical trials a viable treatment for all. Our robust infrastructure, encompassing everything from quality management to both staff and patient education, places our stakeholders at the heart of our operations, and ensures success in every phase of the research journey.

EFFICIENCY AND TRANSPARENCY

We improve research by eliminating redundancy, simplifying administrative processes, through technologically advanced centralized systems.

We’ve launched fully electronic, centralized systems at every site, featuring real-time data entry and access, such as e-Source, patient portals, e-Regulatory. Our quality management, finance, legal, and regulatory department heads are proud to collaborate with FASTRACK, NRG Solutions, and Barrington James to weave in top-tier staff, sustaining quality and efficiency.

TRUSTED CARE, TRUSTED DATA.

Our strength lies in our collaborations with esteemed doctors recognized and trusted throughout the community. This approach ensures efficient patient recruitment and ultimately, resource utilization. Central to our ethos is our commitment to our patients. We’re steadfast in our belief: happy patients yield sound data.

0
Number of clinical trials conducted since 2009
0
number of community members served

Who stands with us?

CONSTANT COLLABORATORS SINCE 2009

A LEGACY OF EXCELLENCE

Pfizer
Synergy Research Centers
Alder Biopharmaceuticals
AMAG Pharmaceuticals
Visterra
Cirius Therapeutics (formerly Octeta)
Dr. Reddy’s Laboratories
Shionogi

Moderna
Pharmacosmos Therapeutics
Symbio
Actavis Generics
IQVIA Biotech (formerly Novella)
Curatek Pharmaceuticals
Evofem Biosciences
Allergan (now merged with Abbvie)

With the Community, For the Community.